No abstract available
Keywords:
Aducanumab; Clinical trials; Donanemab; FDA; Gantenerumab; Lecanemab; Monoclonal antibodies.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alzheimer Disease* / drug therapy
-
Amyloid
-
Amyloid beta-Peptides
-
Amyloidogenic Proteins
-
Antibodies, Monoclonal, Humanized*
-
Humans
Substances
-
Amyloid
-
Amyloid beta-Peptides
-
Amyloidogenic Proteins
-
Antibodies, Monoclonal, Humanized
-
aducanumab